The Global Thulium-167 Market was valued at USD 7.6 Million in 2025 and is projected to reach USD 13.7 Million by 2034, growing at a Compound Annual Growth Rate (CAGR) of 8.6% during the forecast period (2024–2030). This growth is primarily driven by expanding applications in targeted radiotherapy, advancements in medical imaging technologies, and increasing investments in nuclear research infrastructure.

As the demand for precise and effective cancer treatments grows, the spotlight turns to the specialized institutions and companies that produce and supply this critical radioactive isotope. In this blog, we profile the Top 10 Companies in the Thulium-167 Industry—a group of leading research laboratories and nuclear facilities shaping the future of medical isotopes and scientific discovery.

---

🔟 1. CERN (European Organization for Nuclear Research)

Headquarters: Geneva, Switzerland
Key Offering: High-purity Thulium-167 for research, Isotope production via accelerator

CERN is a world-leading laboratory for particle physics, operating the Large Hadron Collider (LHC). While not a commercial supplier, its advanced accelerator complexes are used for fundamental research, including the production and study of rare isotopes like Thulium-167 for scientific experiments conducted by its member states and collaborating institutions.

Research Initiatives:

• Pioneering research in nuclear physics and isotope production techniques

• Collaborations with medical research centers to explore therapeutic applications

• Commitment to advancing fundamental science that underpins future technologies

Download FREE Sample Report: Thulium-167 Market – View in Detailed Research Report

---

9️⃣ 2. Paul Scherrer Institute (PSI)

Headquarters: Villigen, Switzerland
Key Offering: Thulium-167 for research, Proton therapy research support

The Paul Scherrer Institute is Switzerland’s largest research institute for natural and engineering sciences. It operates major research facilities, including a high-intensity proton accelerator, which is used for the production of radioisotopes for medicine and industry, positioning it as a key player in the European research landscape for isotopes like Thulium-167.

Research Initiatives:

• Development of novel radiopharmaceuticals and targeted radiotherapy methods

• Strong focus on translating research into practical medical applications

---

8️⃣ 3. Oak Ridge National Laboratory (ORNL)

Headquarters: Oak Ridge, Tennessee, USA
Key Offering: Reactor-produced Thulium-167, Isotope R&D

ORNL is the largest US Department of Energy science and energy laboratory, with a storied history in isotope production. Its High Flux Isotope Reactor (HFIR) is a leading source of rare isotopes, including Thulium-167, supplied for medical, industrial, and research purposes both domestically and internationally.

Research Initiatives:

• Leading the US isotope production and supply chain for critical medical isotopes

• Pioneering new methods for isotope separation and purification

---

7️⃣ 4. Los Alamos National Laboratory (LANL)

Headquarters: Los Alamos, New Mexico, USA
Key Offering: Thulium-167 research materials, Nuclear science expertise

Los Alamos National Laboratory is a premier national security research institution with significant capabilities in nuclear science. Its expertise in actinide chemistry and radiochemical processing supports the production and characterization of isotopes like Thulium-167 for a variety of national and scientific missions.

Research Initiatives:

• Advanced research in nuclear chemistry and radiopharmaceutical sciences

• Collaborations with the National Nuclear Security Administration on isotope applications

---

6️⃣ 5. SCK CEN (The Belgian Nuclear Research Centre)

Headquarters: Mol, Belgium
Key Offering: Thulium-167 from BR2 reactor, Medical isotope R&D

SCK CEN is a leading European research centre in the field of nuclear energy and radiation protection. Its BR2 reactor is a crucial infrastructure for producing medical isotopes, and the institute conducts extensive research on their applications, including the potential uses of Thulium-167 in medicine.

Research Initiatives:

• Focus on sustainable production of medical isotopes for healthcare

• Research into the safe handling and application of radioactive materials

Download FREE Sample Report: Thulium-167 Market – View in Detailed Research Report

---

5️⃣ 6. ITER Organization

Headquarters: Saint-Paul-lès-Durance, France
Key Offering: Research in fusion-related neutron sources (potential future production)

The ITER Organization is behind the international ITER project, which aims to demonstrate the feasibility of fusion power. While not a current producer, the intense neutron fluxes expected from a future fusion reactor represent a potential long-term, high-volume source for isotopes like Thulium-167, making ITER a significant future-oriented entity.

Research Initiatives:

• Building the world’s largest tokamak for nuclear fusion research

• Exploring future pathways for large-scale isotope production

---

4️⃣ 7. Institute for Radioelements (IRE)

Headquarters: Fleurus, Belgium
Key Offering: Radioisotopes for medicine, Partnership-based production

The IRE is a key player in the European medical isotope market, specializing in the production and distribution of radioisotopes for diagnostic and therapeutic purposes. It collaborates with reactor facilities to ensure a stable supply chain, with a focus on meeting healthcare demands, including for emerging isotopes.

Research Initiatives:

• Securing and diversifying the supply of critical medical radioisotopes

• Investing in new production and purification technologies

---

3️⃣ 8. TRIUMF

Headquarters: Vancouver, Canada
Key Offering: Accelerator-produced isotopes, R&D in life sciences

TRIUMF is Canada’s particle accelerator centre, operating the world’s largest cyclotron. It is a hub for producing rare isotopes for research, including those used in advanced medical imaging and therapy development. Its capabilities support the investigation of isotopes like Thulium-167 for new applications.

Research Initiatives:

• Leading research in accelerator-based isotope production

• Strong collaborations with healthcare institutions for clinical translation

---

2️⃣ 9. Joint Institute for Nuclear Research (JINR)

Headquarters: Dubna, Russia
Key Offering: Research-grade isotopes, Nuclear physics experiments

JINR is an international intergovernmental research organization in Russia. It operates major facilities like the Nuclotron and participates in fundamental research in nuclear physics, which includes the study and production of various isotopes, contributing to the global knowledge base on elements like Thulium-167.

Research Initiatives:

• Conducting fundamental research in nuclear structure and reactions

• International scientific cooperation on advanced nuclear technologies

---

1️⃣ 10. Karlsruhe Institute of Technology (KIT)

Headquarters: Karlsruhe, Germany
Key Offering: Nuclear research, Education and training in radiochemistry

KIT is a leading research university in Germany with significant expertise in energy research, including nuclear technology. Its Institute for Nuclear Waste Disposal and other departments conduct research relevant to the production, handling, and application of radioactive isotopes, supporting the broader ecosystem for materials like Thulium-167.

Research Initiatives:

• Research on nuclear safety, waste management, and radiochemistry

• Contributing to the development of safe isotope handling protocols

Get Full Report Here: Thulium-167 Market – View in Detailed Research Report

---

🔬 Outlook: The Future of Thulium-167 Is Precision Medicine and Advanced Research

The Thulium-167 market is at a pivotal point, transitioning from a niche research isotope to a potential key player in next-generation medical therapies. While scientific research remains the dominant application, the industry is witnessing growing interest in its therapeutic potential, driving investment in production and purification technologies.

📈 Key Trends Shaping the Market:

• Increased focus on targeted alpha therapy (TAT) for precision oncology

• Advancements in accelerator and reactor technology for more efficient isotope production

• Growing international collaborations to secure stable supply chains for medical isotopes

• Rising investment in radiopharmaceutical R&D from both public and private sectors

Get Full Report Here: Thulium-167 Market – View in Detailed Research Report

The organizations listed above are not only producing a critical isotope—they are enabling the next wave of scientific and medical breakthroughs that rely on precise nuclear technologies.